Xenon to Present at Stifel 2025 Virtual CNS Forum

Core Insights - Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to developing therapeutics for patients with high unmet medical needs [3] Group 1: Company Presentation - Xenon Pharmaceuticals will present at the Stifel 2025 Virtual CNS Forum on March 18-19, 2025 [1] - The presentation will feature Dr. Chris Kenney, Chief Medical Officer, on March 19, 2025, from 12:00-12:25 PM Eastern Time [2] - A live audio webcast of the presentation will be available on the company's website and will be posted for replay after the event [2] Group 2: Product Development - The company is advancing an ion channel product portfolio targeting conditions such as epilepsy and depression [3] - Azetukalner is highlighted as a novel, highly potent, selective Kv7 potassium channel opener, currently in late-stage clinical development for multiple indications [3]